Question: Comparing Profitability Ratios for Competitors Selected income statement data for Abbott Laboratories, Bristol-Myers Squibb Company, Johnson & Johnson, GlaxoSmithKline plc, and Pfizer, Inc. is presented
Comparing Profitability Ratios for Competitors
Selected income statement data for Abbott Laboratories, Bristol-Myers Squibb Company, Johnson & Johnson, GlaxoSmithKline plc, and Pfizer, Inc. is presented in the following table:
| ($ millions) | Abbott Laboratories | Bristol- Myers Squibb | Johnson & Johnson | Glaxo Smith Kline plc | Pfizer |
|---|---|---|---|---|---|
| Sales revenue | $40,001 | $22,394 | $66,280 | 28,537 | $68,675 |
| Cost of sales | 15,541 | 5,598 | 20,360 | 7,332 | 15,085 |
| SG&A expense | 12,757 | 5,160 | 20,969 | 8,826 | 19,468 |
| R&D expense | 4,129 | 3,839 | 7,548 | 4,009 | 9,112 |
| Interest expense | 530 | 145 | 571 | 799 | 1,681 |
| Net income | 4,728 | 5,260 | 9,672 | 5,458 | 10,051 |
Required a. Compute the profit margin (PM) and gross profit margin (GPM) ratios for each company. (As a British company, GlaxoSmithKline plc has a statutory tax rate of 26.5% in 2014; assume a statutory rate of 35% for all other companies.) (Round your answers to one decimal place.)
| Abbott Laboratories | Bristol- Myers Squibb | Johnson & Johnson | Glaxo Smith Kline plc | Pfizer | |
|---|---|---|---|---|---|
| PM | Answer | Answer | Answer | Answer | Answer |
| GPM | Answer | Answer | Answer | Answer | Answer |
b. Compute the research and development (R&D) expense to sales ratio and the selling, general and administrative (SG&A) expense to sales ratio for each company. (Round your answers to one decimal place.)
| Abbott Laboratories | Bristol- Myers Squibb | Johnson & Johnson | Glaxo Smith Kline plc | Pfizer | |
|---|---|---|---|---|---|
| R&D ETS | Answer | Answer | Answer | Answer | Answer |
| SG&A ETS | Answer | Answer | Answer | Answer | Answer |
Step by Step Solution
There are 3 Steps involved in it
Get step-by-step solutions from verified subject matter experts
